Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial

NCT05822583 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT05822583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05822583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial
Lead sponsor
University of Minnesota
Phase
Phase 4
Overall status
Completed
Start date
July 6, 2023
Completion date
August 11, 2025
Enrollment
285 (actual)
Sites
127

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19